Literature DB >> 30056040

Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.

Alex A Balekian1, Juan P Wisnivesky2, Michael K Gould3.   

Abstract

BACKGROUND: Low-dose CT scan reduces lung cancer mortality in high-risk patients fit to undergo surgical resection. Racial disparities in resection of lung cancer in nonscreening populations are well described. We describe surgical resection patterns of patients with early stage non-small cell lung cancer (NSCLC) in the National Lung Screening Trial (NLST) and examine whether racial disparities exist among blacks.
METHODS: We identified all NLST participants with clinical stage I NSCLC. Covariates included demographics, smoking history, comorbidities, tumor characteristics, and timing of cancer detection. Using logistic regression, we assessed resection rates of blacks vs whites.
RESULTS: Among 752 patients with clinical stage I disease, 692 patients (92%) underwent resection. Unadjusted surgical resection rates for white men, white women, black men, and black women were 92%, 91%, 61%, and 90%, respectively. In adjusted analyses, compared with white men, black men had a 28% lower risk (relative risk, 0.72; 95% CI, 0.50-0.99) of undergoing surgery; however, white women and black women underwent surgery at comparable rates as white men. The odds of undergoing limited resection instead of full resection were 70% greater in white women than white men (OR, 1.69; 95% CI, 1.08-2.65).
CONCLUSIONS: Our study shows that disparities in the surgical treatment of lung cancer persist, even among NLST participants who were considered fit to undergo thoracic surgery. As lung cancer screening disseminates into clinical practice, efforts targeting black men should be prioritized.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  carcinoma; health-care disparities; minority health; non-small cell lung

Mesh:

Year:  2018        PMID: 30056040     DOI: 10.1016/j.chest.2018.07.011

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Racial difference in BMI and lung cancer diagnosis: analysis of the National Lung Screening Trial.

Authors:  Joy Zhao; Julie A Barta; Russell McIntire; Christine Shusted; Charnita Zeigler-Johnson; Hee-Soon Juon
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

2.  Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.

Authors:  David S Gierada; Paul F Pinsky
Journal:  Chest       Date:  2020-08-19       Impact factor: 9.410

3.  Healthcare disparities in thoracic malignancies.

Authors:  Kei Suzuki; Virginia R Litle
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

4.  Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

Authors:  Ernesto Sosa; Gail D'Souza; Aamna Akhtar; Melissa Sur; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  CA Cancer J Clin       Date:  2021-05-20       Impact factor: 286.130

5.  Long non-coding RNA RFPL3S is a novel prognostic biomarker in lung cancer.

Authors:  Zhonghua Liu; Zhiqiang Ning; Hailin Lu; Tinghua Cao; Feng Zhou; Xia Ye; Chao Chen
Journal:  Oncol Lett       Date:  2020-05-19       Impact factor: 2.967

6.  Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.

Authors:  Umit Tapan; Vanessa Fiorini Furtado; Muhammad Mustafa Qureshi; Peter Everett; Kei Suzuki; Kimberley S Mak
Journal:  JTO Clin Res Rep       Date:  2020-10-20

Review 7.  The role of gender in non-small cell lung cancer: a narrative review.

Authors:  Ioana Baiu; Ashley L Titan; Linda W Martin; Andrea Wolf; Leah Backhus
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

8.  Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.

Authors:  Erik F Blom; Kevin Ten Haaf; Douglas A Arenberg; Harry J de Koning
Journal:  Ann Am Thorac Soc       Date:  2020-02

9.  Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up.

Authors:  Michael Lake; Christine S Shusted; Hee-Soon Juon; Russell K McIntire; Charnita Zeigler-Johnson; Nathaniel R Evans; Gregory C Kane; Julie A Barta
Journal:  BMC Cancer       Date:  2020-06-16       Impact factor: 4.430

10.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.